+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Transdermal Skin Patches Market Report by Type, Distribution Channel, Application, and Region 2024-2032

  • PDF Icon

    Report

  • 136 Pages
  • July 2024
  • Region: Global
  • IMARC Group
  • ID: 5562342
The global transdermal skin patches market size reached US$ 7.9 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 11.2 Billion by 2032, exhibiting a growth rate (CAGR) of 4.0% during 2023-2032.

Transdermal skin patches refer to a non-invasive and easy to use drug delivery method of administering constant and consistent therapeutic dosages into the bloodstream over a predetermined time. They consist of backings, drugs, membranes, adhesives, liners, chemical enhancers and permeators, physical aids, and low electrical current like iontophoresis. They provide a consistent diffusion rate, depending on the characteristics of the skin and the design of the patch. They are nowadays widely used as cosmetic, topical, and transdermal delivery systems around the world.

Transdermal Skin Patches Market Trends:

Transdermal skin patches are effective for treating cardiac and hormonal disorders, migraine, Parkinson’s disease, Alzheimer’s, stroke, human immunodeficiency virus (HIV), osteoporosis, and restless leg syndrome. Thus, a significant increase in the percentage of the population suffering from these ailments represents one of the key factors impelling the market growth. Moreover, these patches help avoid the traditional oral route for ingesting medicines, lower the inconvenience caused due to intravenous or parenteral therapies, and prevent gastrointestinal toxicity, nausea, and vomiting. Furthermore, due to the ease of administration, transdermal skin patches are gaining traction to improve the compliance of the patient during prolonged treatments for chronic pains and in smoking cessation therapy. Apart from this, the escalating demand for better therapeutics at affordable costs, coupled with a significant rise in the number of clinical trials of different drugs classes, is positively influencing the market. Furthermore, the introduction of pressure-sensitive adhesives and permeation enhancers, which lead to increased product diffusion and enhanced drug retention ability, is anticipated to provide lucrative opportunities to market players and expand the application of transdermal skin patches across the globe in the coming years.

Key Market Segmentation:

The report provides an analysis of the key trends in each sub-segment of the global transdermal skin patches market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, distribution channel and application.

Breakup by Type:

Single-layer Drug-in-Adhesive
Multi-layer Drug-in-Adhesive
Matrix
Others

Breakup by Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Stores

Breakup by Application:

Pain Relief
Smoking Reduction and Cessation Aid
Overactive Bladder
Hormonal Therapy
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, AdhexPharma, LTS Lohmann Therapie-Systeme AG, Luye Pharma Group, Medherant Limited, Nitto Denko Corporation, Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.), Prosolus Inc., Samyang Holdings Corporation, Tapemark, Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd), tesa SE (Beiersdorf AG) and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

1. What was the size of the global transdermal skin patches market in 2023?
2. What is the expected growth rate of the global transdermal skin patches market during 2024-2032?
3. What are the key factors driving the global transdermal skin patches market?
4. What has been the impact of COVID-19 on the global transdermal skin patches market?
5. What is the breakup of the global transdermal skin patches market based on the type?
6. What is the breakup of the global transdermal skin patches market based on the application?
7. What are the key regions in the global transdermal skin patches market?
8. Who are the key players/companies in the global transdermal skin patches market?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Transdermal Skin Patches Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Single-layer Drug-in-Adhesive
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Multi-layer Drug-in-Adhesive
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Matrix
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Distribution Channel
7.1 Hospital Pharmacies
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Retail Pharmacies
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Online Stores
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Application
8.1 Pain Relief
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Smoking Reduction and Cessation Aid
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Overactive Bladder
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Hormonal Therapy
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 3M Company
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 AdhexPharma
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 LTS Lohmann Therapie-Systeme AG
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Luye Pharma Group
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Medherant Limited
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Nitto Denko Corporation
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 SWOT Analysis
14.3.8 Prosolus Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Samyang Holdings Corporation
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Tapemark
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd)
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 tesa SE (Beiersdorf AG)
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.13 Teva Pharmaceutical Industries Ltd
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
14.3.13.4 SWOT Analysis
List of Figures
Figure 1: Global: Transdermal Skin Patches Market: Major Drivers and Challenges
Figure 2: Global: Transdermal Skin Patches Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Transdermal Skin Patches Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Transdermal Skin Patches Market: Breakup by Type (in %), 2023
Figure 5: Global: Transdermal Skin Patches Market: Breakup by Distribution Channel (in %), 2023
Figure 6: Global: Transdermal Skin Patches Market: Breakup by Application (in %), 2023
Figure 7: Global: Transdermal Skin Patches Market: Breakup by Region (in %), 2023
Figure 8: Global: Transdermal Skin Patches (Single-layer Drug-in-Adhesive) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Transdermal Skin Patches (Single-layer Drug-in-Adhesive) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Transdermal Skin Patches (Multi-layer Drug-in-Adhesive) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Transdermal Skin Patches (Multi-layer Drug-in-Adhesive) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Transdermal Skin Patches (Matrix) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Transdermal Skin Patches (Matrix) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Transdermal Skin Patches (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Transdermal Skin Patches (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Transdermal Skin Patches (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Transdermal Skin Patches (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Transdermal Skin Patches (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Transdermal Skin Patches (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Transdermal Skin Patches (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Transdermal Skin Patches (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Transdermal Skin Patches (Pain Relief) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Transdermal Skin Patches (Pain Relief) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Transdermal Skin Patches (Smoking Reduction and Cessation Aid) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Transdermal Skin Patches (Smoking Reduction and Cessation Aid) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Transdermal Skin Patches (Overactive Bladder) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Transdermal Skin Patches (Overactive Bladder) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Transdermal Skin Patches (Hormonal Therapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Transdermal Skin Patches (Hormonal Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Transdermal Skin Patches (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Transdermal Skin Patches (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: North America: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: North America: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: United States: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: United States: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Canada: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Canada: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Asia-Pacific: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Asia-Pacific: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: China: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: China: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Japan: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Japan: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: India: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: India: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: South Korea: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: South Korea: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Australia: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Australia: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Indonesia: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Indonesia: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Others: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Europe: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Europe: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Germany: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Germany: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: France: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: France: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: United Kingdom: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: United Kingdom: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Italy: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Italy: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Spain: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Spain: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Russia: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Russia: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Others: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Latin America: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Latin America: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Brazil: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Brazil: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Mexico: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Mexico: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Others: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Middle East and Africa: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Middle East and Africa: Transdermal Skin Patches Market: Breakup by Country (in %), 2023
Figure 80: Middle East and Africa: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Global: Transdermal Skin Patches Industry: SWOT Analysis
Figure 82: Global: Transdermal Skin Patches Industry: Value Chain Analysis
Figure 83: Global: Transdermal Skin Patches Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Transdermal Skin Patches Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Transdermal Skin Patches Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Transdermal Skin Patches Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 4: Global: Transdermal Skin Patches Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: Transdermal Skin Patches Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Transdermal Skin Patches Market: Competitive Structure
Table 7: Global: Transdermal Skin Patches Market: Key Players

Companies Mentioned

  • 3M Company
  • AdhexPharma
  • LTS Lohmann Therapie-Systeme AG
  • Luye Pharma Group
  • Medherant Limited
  • Nitto Denko Corporation
  • Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.)
  • Prosolus Inc.
  • Samyang Holdings Corporation
  • Tapemark
  • Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd)
  • tesa SE (Beiersdorf AG)
  • Teva Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...

Table Information